Role of Chemoreceptor Activation in Hemodynamic Responses to Electrical Stimulation of the Carotid Sinus in Conscious Rats.
Role of Chemoreceptor Activation in Hemodynamic Responses to Electrical Stimulation of the Carotid Sinus in Conscious Rats.
复制标题
DOI:
10.1161/hypertensionaha.115.05316
复制
发表时间:
2015-09
期刊:
影响因子:
--
通讯作者:
Salgado HC
中科院分区:
文献类型:
--
作者:
Katayama PL;Castania JA;Dias DP;Patel KP;Fazan R Jr;Salgado HC
Electrical carotid baroreflex activation has been used to treat patients with resistant hypertension. It is hypothesized that, in conscious rats, combined activation of carotid baro- and chemoreceptors afferences attenuates the reflex hypotension. Rats were divided into 4 groups: 1) control group, with unilateral denervation of the right carotid chemoreceptors; 2) chemoreceptor denervation group, with bilateral ligation of the carotid body artery; 3) baroreceptor denervation group, with unilateral denervation of the left carotid baroreceptors and right carotid chemoreceptors; 4) carotid bifurcation denervation group, with denervation of the left carotid baroreceptors and chemoreceptors, plus denervation of the right carotid chemoreceptors. Animals were subjected to 4 rounds of electrical stimulation (5 V, 1 ms), with 15 Hz, 30 Hz, 60 Hz, and 90 Hz applied randomly for 20 s. Electrical stimulation caused greater hypotensive responses in the chemoreceptor denervation group than in the control group, at 60 Hz (−37 mmHg vs −19 mmHg) and 90 Hz (−33 mmHg vs −19 mmHg). The baroreceptor denervation group showed hypertensive responses at all frequencies of stimulation. In contrast, the carotid sinus denervation group showed no hemodynamic responses. The control group presented no changes in heart rate, whereas the chemoreceptor denervation group and the baroreceptor denervation group showed bradycardic responses. These data demonstrate that carotid chemoreceptor activation attenuates the reflex hypotension caused by combined electrical stimulation of the carotid sinus and the carotid sinus nerve in conscious rats. These findings may provide useful insight for clinical studies using Baroreflex Activation Therapy in resistant hypertension and/or heart failure.